United States · FDA National Drug Code directory
XTORO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83709-001_9db61e18-114c-46c5-bdc2-5f56c4b2f87f
- Product NDC
- 83709-001
- Form
- SUSPENSION
- Composition / generic term
- finafloxacin
- Labeler
- Fonseca Biosciences, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260501
- Source listing expiry
- 20271231
Source-listed ingredients
- FINAFLOXACIN — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (83709-001-01) / 5 mL in 1 BOTTLE, DROPPER · 83709-001-01
- 1 POUCH in 1 CARTON (83709-001-90) / 1 BOTTLE, DROPPER in 1 POUCH / 1.5 mL in 1 BOTTLE, DROPPER · 83709-001-90
- 1 BOTTLE, DROPPER in 1 CARTON (83709-001-91) / 5 mL in 1 BOTTLE, DROPPER · 83709-001-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →